At 13.0x FY19E Normalised NPAT, the market is not only discounting any future growth acceleration from CIPRs, but now essentially starting to price in a significant slowdown in the current Life book growth rate.
With nearly 50% of the book expected to mature within the next three years, and being replaced with longer maturities, that would require an absolute collapse in new annuity sales. Possible, but (from what I can see) very unlikely.
At 13.0x FY19E Normalised NPAT, the market is not only...
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CGF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.89 |
Change
0.020(0.29%) |
Mkt cap ! $4.761B | |||
| Open | High | Low | Value | Volume |
| $6.95 | $6.99 | $6.88 | $7.286M | 1.052M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1818 | $6.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.90 | 13335 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CGF (ASX) Chart |